Skip to content

Study · Case report or series · n = 1 · 2025

2 results

Problematic Pharmacokinetics: A Case of Recurrent Pancreatitis Post Discontinuation of a Glucagon-Like Peptide 1 Receptor Agonists.

Morehouse ZP, Ledford JD

Journal of pharmacy practice7 Aug 2024Cited by 2 (Europe PMC)

PMID39109559 (opens in a new tab)DOI10.1177/08971900241273188 (opens in a new tab)PepBankPUB-39109559
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesSafety outcome

    In a 53-year-old woman with uncontrolled type 2 diabetes, multiple pancreatitis episodes were suspected to be due to repeated semaglutide exposure.

    In plain wordsIn a 53-year-old woman with diabetes, repeated semaglutide exposure was suspected in multiple pancreatitis episodes.

    Peptide
    Semaglutide
    Outcome
    Not applicableRecurrent pancreatitis
    Study

    n = 1

    Outcome group
    Adverse events · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We describe the case of a 53-year-old female patient with uncontrolled type II diabetes mellitus, who experienced multiple episodes of pancreatitis, from what we suspect was due to repeated exposure to the GLP-1 RA agent, semaglutide.
  2. 02HumanCase report or seriesSafety outcome

    In a 53-year-old woman with uncontrolled type 2 diabetes, pancreatitis recurred roughly 15 weeks after semaglutide discontinuation.

    In plain wordsIn a 53-year-old woman with diabetes, pancreatitis recurred roughly 15 weeks after semaglutide was stopped.

    Peptide
    Semaglutide
    Outcome
    Not applicablePancreatitis after discontinuation
    Study

    n = 1

    Outcome group
    Adverse events · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    After discontinuation of semaglutide, our patient experienced another episode of pancreatitis roughly 15-week later; which we believe may be due to the patient experiencing the effects of a smoldering pancreas brought on by repeated injury and prolonged circulation of semaglutide post-discontinuation.
    1 context sentence
    Summary · context
    We describe the case of a 53-year-old female patient with uncontrolled type II diabetes mellitus, who experienced multiple episodes of pancreatitis, from what we suspect was due to repeated exposure to the GLP-1 RA agent, semaglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:06 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.